MYO1E antibody

Catalog No. ABIN7116614

Product Details anti-MYO1E Antibody

Target: MYO1E (Myosin IE (MYO1E))

Reactivity: Human, Mouse, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MYO1E antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Purification: Immunogen affinity purified

Purity: ≥95 % as determined by SDS-PAGE

Immunogen: myosin IE

Isotype: IgG

Application Details

Application Notes: WB: 1:500-1:2000

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Expiry Date: 12 months

Target Details for MYO1E

Target: MYO1E (Myosin IE (MYO1E))

Alternative Name: MYO1E (MYO1E Products)

Synonyms: FSGS6 antibody, HuncM-IC antibody, MYO1C antibody, MYR5 antibody, Myr3 antibody, 2310020N23Rik antibody, 9130023P14Rik antibody, AA407778 antibody, myosin-1e antibody, myr 3 antibody, myo1e antibody, wu:fc15g04 antibody, wu:fe49h01 antibody, myosin IE antibody, myosin IE, a antibody, MYO1E antibody, Myo1e antibody, myo1ea antibody

Background: Synonyms:MYO1C Background:Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. Binds to membranes containing anionic phospholipids via its tail domain. Required for normal morphology of the glomerular basement membrane, normal development of foot processes by kidney podocytes and normal kidney function. In dendritic cells, may control the movement of class II-containing cytoplasmic vesicles along the actin cytoskeleton by connecting them with the actin network via ARL14EP and ARL14.

Molecular Weight: 127 kDa

Gene ID: 4643

UniProt: Q12965

Pathways: Platelet-derived growth Factor Receptor Signaling